64.7 %The overall Plasmodium prevalence was 64.7% as detected by PCR.
Camerounpaludismeobserved November 2020published 2023Parasites & vectorseurope_pmcdocument of 16 observationsDOI 10.1186/s13071-022-05635-7
Gold tier: mechanically validated evidence, with its primary source.
1,754 evidence items · page 1 / 71
64.7 %The overall Plasmodium prevalence was 64.7% as detected by PCR.
Camerounpaludismeobserved November 2020published 2023Parasites & vectorseurope_pmcdocument of 16 observationsDOI 10.1186/s13071-022-05635-7
In a clinical trial, capsaicin reduced median pain intensity to 3.0 [2.5–3.3] at four weeks compared to 5.0 [4.2–5.5] in the placebo group (p=0.02).
Camerounpainful diabetic neuropathypublished 2020Cureuseurope_pmcdocument of 5 observationsDOI 10.7759/cureus.11147
89.8 %Specificity for the detection of mild nonproliferative diabetic retinopathy using the smartphone-based retinal camera was 89.8%.
Camerounmild nonproliferative diabetic retinopathypublished 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument of 16 observations
75.1 %The prevalence of undiagnosed diabetes in low-income countries in the Africa Region (AFR) was 75.1%.
Camerounundiagnosed diabetespublished 2014Diabetes research and clinical practiceeurope_pmcdocument of 14 observations
74,000,000 individualsIn 2016, 74 million boys worldwide were obese.
Camerounobésitéobserved 2016published 2017Lancet (London, England)europe_pmcdocument of 12 observations
0.478 kappa_statisticThere was only moderate agreement (kappa=0.478, 95% CI: 0.455–0.502) between the two values in the stratification of cardiovascular risk according to the National Cholesterol Education Program/Adult Treatment Panel III.
Camerounmaladies cardiovasculairesobserved March 2012 to January 2016published 2018Clinical biochemistryeurope_pmcdocument of 4 observations
57,600,000 YLDsGlobally, low back pain was the leading cause of years lived with disability (YLDs) in 2016, contributing 57.6 million YLDs.
CamerounLow Back Painobserved 2016published 2017Lancet (London, England)europe_pmcdocument of 5 observationsDOI 10.1016/s0140-6736(17)32154-2
6.5 %From 2009 to 2012, the prevalence of abdominal obesity in women increased from 6.5% to 11.7%.
Camerounabdominal obesityobserved 2009 to 2012published 2017BMC public healtheurope_pmcdocument of 9 observations
11 %Clade G accounted for 11% of the studied HIV infections in Cameroonian blood donors.
CamerounVIH/sidapublished 2013Virology JournalOpenAlexdocument of 7 observationsDOI 10.1186/1743-422x-10-29
1.6 %Globally, prevalence of morbid obesity was 1.6% in women.
Camerounobésitépublished 2016Lancet (London, England)europe_pmcdocument of 20 observations
24.2 %Among patients with type 2 diabetes diagnosed with hypertension, angiotensin II receptor blocker use increased from 24.2% in wave 1 to 43.6% in wave 7.
Cameroundiabète de type 2 · hypertension artériellepublished 2021Diabetologiaeurope_pmcdocument of 14 observations
3 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à entre 3 et 4 par mois chez les enfants de moins de 5 ans.
CameroundrépanocytoseHAL · Unilimdocument of 75 observations
52 %Awareness of asthma among those with current wheeze was 52% to 58% in urban areas.
Camerounasthmepublished 2004Tropical doctoreurope_pmcdocument of 10 observations
60 %Sixty percent of the 142 strains had one mutation in the protease gene.
CamerounVIH/sidapublished 2000Journal of Clinical MicrobiologyOpenAlexdocument of 19 observations
27.7 %The percentage of participants with obesity increased from 6.9% to 27.7% on DTG/TDF/3TC.
Camerounobésitépublished 2023Open Forum Infectious DiseasesOpenAlexdocument of 8 observationsDOI 10.1093/ofid/ofad582
349 cases349 out of 612 sickle cell disease patients had extracardiac organ damages including stroke, leg ulcer, priapism, microalbuminuria or osteonecrosis in Cameroon, Mali, and Senegal.
Cameroun · Mali · SénégaldrépanocytoseHAL · Unilimdocument of 2 observations
1 %If post-2000 trends continue, the probability of meeting the global target of halting the rise in the prevalence of diabetes by 2025 at the 2010 level worldwide is lower than 1% for men.
Cameroundiabète (non précisé)observed 2025published 2016Lancet (London, England)europe_pmcdocument of 7 observationsDOI 10.1016/s0140-6736(16)00618-8
All patients with untreated and recently diagnosed hyperthyroidism presented abnormal results for parasympathetic activity.
Camerounhyperthyroidismpublished 2018BMC research noteseurope_pmcdocument of 6 observations
In a clinical trial, capsaicin reduced median pain intensity to 3.3 [2.5–4.0] at six weeks compared to 4.8 [4.0–6.0] in the placebo group (p=0.03).
Camerounpainful diabetic neuropathypublished 2020Cureuseurope_pmcdocument of 5 observationsDOI 10.7759/cureus.11147
1,070 SFU/10^6 PBMCThe median T cell response to Nef was 1070 spot forming units per 10^6 PBMC.
CamerounVIH/sidapublished 2009RetrovirologyOpenAlexdocument of 6 observationsDOI 10.1186/1742-4690-6-s3-p273
54.8 %In Mfou, malaria prevalence among females was 54.8%.
CamerounpaludismeHAL · Unilimdocument of 106 observations
5.3 %Among ART initiators with no prior exposure to antiretrovirals in rural areas of Cameroon, pretreatment HIV drug resistance (PDR) prevalence was 5.3% (95% CI 1.4%–17.5%).
CamerounVIH/sidaobserved 2015published 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument of 12 observationsDOI 10.1093/jac/dky221
29.7 %Age-standardised rates of disability-adjusted life-years (DALYs) due to neurological disorders decreased by 29.7% between 1990 and 2015.
Camerounneurological disordersobserved 1990–2015published 2017The Lancet. Neurologyeurope_pmcdocument of 10 observations
64.1 %Cup/Disc ratio (C/D) ≥0.5 was found in 64.1% (25/39) of patients with suspicion of glaucoma.
Camerounglaucomapublished 2020Medical hypothesis, discovery & innovation ophthalmology journaleurope_pmcdocument of 8 observations
11.1 %The prevalence of foot lesions among outpatients was 11.1%.
Camerounpied diabétiquepublished 2006The international journal of lower extremity woundseurope_pmcdocument of 10 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.